Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG for Esophagus Protection in Lung Cancer Radiotherapy
NCT02577393Phase 2Unknown
- Sponsor
- Shandong Cancer Hospital
- Start
- Apr 2015
- Primary completion
- Jun 2022
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of epigallocatechin gallate in radiation-induced esophagitis, sponsored by Shandong Cancer Hospital. Status: unknown.
02
Drugs
epigallocatechin gallate
03
Conditions
radiation-induced esophagitis
Beyond the preview
Go deeper on NCT02577393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02577393.